
ASX
CSL Shares Tumble as Trump’s Pharmaceutical Tariff Bombshell Rocks Australian Markets
Australia’s pharmaceutical giant CSL has become the latest casualty in President Donald Trump…
COLITCO LLP accepts no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. COLITCO LLP or an associate may receive a commission for funds raised.